potential COVID-19 treatments living meta-analysis of clinical studies

table network network 2

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID-19 severe or critically

	COVID-19 severe or critically
potential COVID-19 treatments
adjuvant therapies
anticoagulant
anticoagulant, curative dose	REMAP-CAP, ACTIV-4a, ATTACC ... COVID-PACT
anticoagulation, intermediate prophylactic dose	INSPIRATION
anti-inflammatoty and immuno-therapy
anti-inflammatory therapies
stem cells	Shu Shi
corticosteroids
dexamethasone	DEXA-COVID19 CODEX ... Jamaati
Dexamethasone 12mg	COVID STEROID 2
Hydrocortisone	CAPE-COVID Munch ...
methylprednisolone	Steroids-SARI
Immunostimulants drugs
convalescent plasma treatment	CP-COVID-19 Li Rasheed O’Donnell PlasmAr CAPSID AlQahtani REMAP-CAP ... RECOVER Pouladzadeh Sekine ...
immunoglobulin therapy	Tabarsi Raman
interferon
IFN beta-1a	Darazam ... Kalil ...
IFN beta-1b	Rahmani Darazam ...
neutralizing antibody
equine polyclonal antibodies INM005	Lopardo
Immunosuppressants drugs
adalimumab	Fakharian
anti-interleukin-6
Levilimab	V.Lomakin ...
sarilumab	sarilumab Sanofi phase 3 outside US
sarilumab high dose (400mg)	Lescure ...
sarilumab low dose (200mg)	Lescure ...
tocilizumab	MARIPOSA COVACTA ... CORIMUNO-TOCI-1 ... REMAP-CAP ... Veiga Talaschian CORIMUNO-TOCI-ICU ... Rosas ...
canakinumab	CAN-COVID
janus kinase (JAK) inhibitor
baricitinib	COV-BARRIER ...
ruxolitinib	Cao
TD-0903
TD-0903 10mg	Singh ...
TD-0903 1mg	Singh ...
TD-0903 3mg	Singh ...
Kinase inhibitors
imatinib	Aman
antiviral and associated therapy
azithromycin	COALITION II Covid-19 Brazil ...
chloroquine and derivatives
hydroxychloroquine	HYDRA ...
ivermectin	Galan Galan
lopinavir/ritonavir	Cao REMAP-CAP ...
Lopinavir/ritonavir plus hydroxychloroquine	REMAP-CAP ...
remdesivir	CAP-China ...
miscellaneous
pyridostigmine	Fragoso-Saavedra ...
Oral antidiabetic drugs
DPP-4 inhibitor	Abuhasira
Vitamins
vitamin C	Zhang

0 studies excluded by filtering options 0